Effect of previous and current vaccination against influenza A(H1N1) pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain

被引:17
|
作者
Gherasim, Alin [1 ]
Martinez-Baz, Ivan [2 ,3 ]
Castilla, Jesus [2 ,3 ]
Pozo, Francisco [4 ]
Larrauri, Amparo [1 ,3 ]
机构
[1] Carlos III Hlth Inst, Natl Epidemiol Ctr, Madrid, Spain
[2] IdiSNA Navarra Inst Hlth Res, Inst Salud Publ & Laboral Navarra, Pamplona, Spain
[3] Inst Hlth Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
[4] Carlos III Hlth Inst, WHO Natl Influenza Ctr, Natl Influenza Reference Lab, Natl Ctr Microbiol, Madrid, Spain
来源
PLOS ONE | 2017年 / 12卷 / 06期
关键词
TEST-NEGATIVE DESIGN; SEASON; VACCINES; CIRCULATION; PROTECTION; EFFICACY;
D O I
10.1371/journal.pone.0179160
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Recent studies suggest that the protective effect of the current influenza vaccine could be influenced by vaccination in previous seasons. We estimated the combined effect of the previous and current influenza vaccines from the 2010-2011 season to the 2015-2016 season in Spain. Methods We performed a test-negative case-control study in patients >= 9 years old. We estimated the influenza vaccine effectiveness (IVE) against influenza A(H1N1) pdm09, A(H3N2), and B virus. Results We included 1206 influenza A(H1N1) pdm09 cases, 1358 A(H3N2) cases and 1079 B cases. IVE against A(H1N1) pdm09 virus in the pooled-season analysis was 53% (95% Confidence Interval (CI): 21% to 72%) for those vaccinated only in the current season and 50% (95% CI: 23% to 68%) for those vaccinated in the both current and previous seasons. Against the influenza A(H3N2) virus, IVE was 17% (95% CI: -43% to 52%) for those vaccinated only in the current season and 3% (95% CI: -33% to 28%) for those vaccinated in both seasons. Regarding influenza B, we obtained similar IVEs for those vaccinated only in the current and those vaccinated in both seasons: 57% (95% CI: 12% to 79%) and 56% (95% CI: 36% to 70%), respectively. Conclusion Our results suggested no interference between the previous and current influenza vaccines against A(H1N1) pdm09 and B viruses, but a possible negative interference against A (H3N2) virus.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Functional Balance between the Hemagglutinin and Neuraminidase of Influenza A(H1N1)pdm09 HA D222 Variants
    Casalegno, Jean-Sebastien
    Ferraris, Olivier
    Escuret, Vanessa
    Bouscambert, Maude
    Bergeron, Corinne
    Lines, Laetitia
    Excoffier, Thierry
    Valette, Martine
    Frobert, Emilie
    Pillet, Sylvie
    Pozzetto, Bruno
    Lina, Bruno
    Ottmann, Michele
    PLOS ONE, 2014, 9 (08):
  • [42] Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015
    Tandel, Kundan
    Sharma, Shashi
    Dash, Paban Kumar
    Parida, ManMohan
    JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (05) : 836 - 843
  • [43] Influenza A(H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients
    Ohfuji, Satoko
    Fukushima, Wakaba
    Sasaki, Yachiyo
    Tamori, Akihiro
    Kurai, Osamu
    Kioka, Kiyohide
    Maeda, Kazuhiro
    Maeda, Akiko
    Hirota, Yoshio
    LIVER INTERNATIONAL, 2014, 34 (05) : 700 - 706
  • [44] Low response to a monovalent inactivated unadjuvanted influenza A (H1N1) pdm09 vaccine in pediatricians of a general hospital in Japan
    Hata, Atsuko
    Mano, Chihiro
    Nakamura, Yoshie
    Nishida, Hitoshi
    Kumakura, Akira
    Mizumoto, Hiroshi
    Yoshioka, Takakazu
    Yoshida, Yoko
    Shiota, Mitsutaka
    Hata, Daisuke
    Takahashi, Kazuo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (05) : 587 - 591
  • [45] The priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort study
    Kang, Eun Kyeong
    Eun, Byung Wook
    Kim, Nam Hee
    Lim, Jung Sub
    Lee, Jun Ah
    Kim, Dong Ho
    BMC INFECTIOUS DISEASES, 2016, 16
  • [46] Adverse events following vaccination against pandemic influenza A (H1N1) 2009 in children
    de Andrade, Gisele Nepomuceno
    Pimenta, Adriano Marcal
    Silva, Debora Arreguy
    Faria Madeira, Anezia Moreira
    CADERNOS DE SAUDE PUBLICA, 2012, 28 (09): : 1713 - 1724
  • [47] Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge
    Yang, Huanliang
    Chen, Yan
    Shi, Jianzhong
    Guo, Jing
    Xin, Xiaoguang
    Zhang, Jian
    Wang, Dayan
    Shu, Yuelong
    Qiao, Chuanling
    Chen, Hualan
    VETERINARY MICROBIOLOGY, 2011, 152 (3-4) : 229 - 234
  • [48] Hemagglutination Inhibition Antibody Titers as Mediators of Influenza Vaccine Efficacy Against Symptomatic Influenza A(H1N1), A(H3N2), and B/Victoria Virus Infections
    Lim, Wey Wen
    Feng, Shuo
    Wong, Sook-San
    Sullivan, Sheena G.
    Cowling, Benjamin J.
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (01) : 152 - 160
  • [49] Protective Effect of Korean Red Ginseng Extract on the Infections by H1N1 and H3N2 Influenza Viruses in Mice
    Yoo, Dae-Goon
    Kim, Min-Chul
    Park, Min-Kyung
    Song, Jae-Min
    Quan, Fu-Shi
    Park, Kyoung-Mi
    Cho, Young-Keol
    Kang, Sang-Moo
    JOURNAL OF MEDICINAL FOOD, 2012, 15 (10) : 855 - 862
  • [50] Humoral and Cell-Mediated Immunity to Pandemic H1N1 Influenza in a Canadian Cohort One Year Post-Pandemic: Implications for Vaccination
    Wagar, Lisa E.
    Rosella, Laura
    Crowcroft, Natasha
    Lowcock, Beth
    Drohomyrecky, Paulina C.
    Foisy, Julie
    Gubbay, Jonathan
    Rebbapragada, Anu
    Winter, Anne-Luise
    Achonu, Camille
    Ward, Brian J.
    Watts, Tania H.
    PLOS ONE, 2011, 6 (11):